Inborn Errors of Metabolism Knowledgebase
Inborn errors of metabolism (IEMs) represent a large class of rare genetic disorders. The first IEM was described in 1902 by Sir Archibald Garrod. Since then, many more have been described, variously estimated as >600 or >700. We established a proposed nosology of IEMs, by first defining specific criteria to include a disorder as an IEM, in an attempt to create a self-consistent schema. Our initial approach identified 1015 well-characterized inborn errors of metabolism described in the literature. In addition, there were 111 less well-characterized conditions that may be IEMs but do not meet strict criteria for inclusion in the current nosology, although it is likely that many of these provisional IEMs will eventually be confirmed.
By necessity, the nosology is subject to constant revision as a result of the rapid pace of progress in the field of genetics. Thus, as new disorders are discovered, and our understanding of the pathophysiology of existing disorders continues to improve, frequent updates to the current nosology will be critical to maintain its usefulness. The purpose of this website is to facilitate the continuous digital update of the nosology via the IEMbase.
Ferreira CR, van Karnebeek CDM, Vockley J, Blau N. A proposed nosology of inborn errors of metabolism. Genet Med. 2018 Jun 8. doi: 10.1038/s41436-018-0022-8. [Epub ahead of print] PubMed PMID: 29884839.
A. DISORDERS OF NITROGEN-CONTAINING COMPOUNDS |
1. Disorders of pyrimidine metabolism |
2. Disorders of purine metabolism |
3. Disorders of nucleotide metabolism |
4. Disorders of creatine metabolism |
5. Disorders of choline metabolism |
6. Disorders of glutathione metabolism |
7. Disorders of ammonia detoxification |
8. Disorders of amino acid transport |
9. Aminoacylase deficiencies |
10. Disorders of monoamine metabolism |
11. Disorders of phenylalanine and tetrahydrobiopterin metabolism |
12. Disorders of tyrosine metabolism |
13. Disorders of sulfur amino acid and sulfide metabolism |
14. Disorders of branched-chain amino acid metabolism |
15. Disorders of lysine metabolism |
16. Disorders of proline and ornithine metabolism |
17. Disorders of β- and γ-amino acids |
18. Disorders of histidine metabolism |
19. Disorders of tryptophan metabolism |
20. Disorders of glutamate metabolism |
21. Disorder of glutamine metabolism |
22. Disorder of asparagine metabolism |
23. Disorders of serine metabolism |
24. Disorders of glycine metabolism |
B. DISORDERS OF VITAMINS, COFACTORS AND MINERALS |
25. Disorders of lipoic acid and iron-sulfur metabolism |
26. Disorders of cobalamin metabolism |
27. Disorders of folate metabolism |
28. Disorders of biotin metabolism |
29. Disorders of thiamine metabolism |
30. Disorders of riboflavin metabolism |
31. Disorders of niacin and NAD metabolism |
32. Disorders of pantothenate metabolism |
33. Disorders of pyridoxine metabolism |
34. Disorder of vitamin C metabolism |
35. Disorders of vitamin A metabolism |
36. Disorders of vitamin D metabolism |
37. Disorder of vitamin E metabolism |
38. Disorders of vitamin K metabolism |
39. Disorders of molybdenum metabolism |
40. Disorders of copper metabolism |
41. Disorders of iron metabolism |
42. Disorders of zinc metabolism |
43. Disorders of manganese metabolism |
44. Disorders of selenium metabolism |
45. Disorders of magnesium metabolism |
C. DISORDERS OF CARBOHYDRATES |
46. Disorders of carbohydrate transport and absorption |
47. Disorders of galactose metabolism |
48. Disorders of fructose metabolism |
49. Disorders of the pentose phosphate pathway and polyol metabolism |
50. Disorders of insulin secretion and signaling |
51. Glycogen storage diseases |
52. Disorders of gluconeogenesis |
Cytosolic phosphoenolpyruvate carboxykinase deficiency |
53. Disorders of glycolysis |
D. MITOCHONDRIAL DISORDERS OF ENERGY METABOLISM |
54. Disorders of pyruvate metabolism |
55. Disorders of the Krebs cycle |
56. Disorders of metabolite repair |
57. Disorders of mitochondrial carriers |
58. Disorders of complex I subunits |
59. Disorders of complex I assembly |
60. Disorders of complex II subunits |
61. Disorders of complex II assembly |
62. Disorders of complex III subunits |
63. Disorders of complex III assembly |
64. Disorders of complex IV subunits |
65. Disorders of complex IV assembly and ancillary proteins |
66. Disorders of complex V subunits |
67. Disorders of complex V assembly |
68. Disorders of mitochondrial cytochrome synthesis and incorporation |
69. Disorders of mitochondrial DNA depletion, multiple deletion, or intergenomic communication |
70. Disorders of mitochondrial transcription and RNA transcript processing |
71. Mitochondrial ribosomopathies |
72. Disorders of mitochondrial translation factors |
73. Disorders of mitochondrial tRNA |
74. Disorders of mitochondrial tRNA incorporation and recycling |
75. Disorders of mitochondrial fission |
76. Disorders of mitochondrial fusion |
77. Disorders of mitochondrial phospholipid metabolism |
78. Disorders of mitochondrial protein import |
79. Disorders of mitochondrial protein quality control |
80. Other disorders of mitochondrial homeostasis |
81. Primary CoQ10 deficiencies |
E. DISORDERS OF LIPIDS |
82. Disorders of carnitine metabolism |
83. Disorders of fatty acid oxidation and transport |
84. Disorders of ketone body metabolism |
85. Disorders of fatty acid synthesis and elongation |
86. Disorder of fatty aldehyde metabolism |
87. Disorders of glycerol metabolism |
88. Disorders of cytoplasmic triglyceride metabolism |
89. Disorders of non-mitochondrial phospholipid metabolism |
90. Disorders of non-lysosomal sphingolipid metabolism |
91. Disorders of eicosanoid metabolism |
92. Disorders of palmitoylation |
93. Disorders of phosphoinositide metabolism |
94. Disorders of lipoprotein metabolism |
95. Disorders of cholesterol biosynthesis |
96. Disorders of steroid metabolism |
97. Disorders of bile acid synthesis |
F. DISORDERS OF TETRAPYRROLES |
98. Disorders of heme metabolism |
99. Disorders of bilirubin metabolism and biliary transport |
G. STORAGE DISORDERS |
100. Disorders of autophagy |
101. Neuronal ceroid lipofuscinosis |
102. Sphingolipidoses |
103. Oligosaccharidoses |
104. Mucolipidoses |
105. Mucopolysaccharidoses |
106. Disorders of lysosomal cholesterol metabolism |
107. Disorders of lysosomal transport or sorting |
108. Disorders of lysosomal protein degradation |
H. DISORDERS OF PEROXISOMES AND OXALATE |
109. Disorders of plasmalogen synthesis |
110. Disorders of peroxisomal β-oxidation |
111. Disorder of peroxisomal α-oxidation |
112. Disorders of peroxisomal biogenesis |
113. Peroxisomal disorders not involving lipid metabolism |
114. Disorders of oxalate metabolism |
I. CONGENITAL DISORDERS OF GLYCOSYLATION |
115. Disorders of N-linked glycosylation |
116. Disorders of O-mannosylation |
117. Disorders of O-xylosylation and glycosaminoglycan synthesis |
118. Disorders of O-GalNAcylation |
119. Disorders of O-GlcNAcylation |
120. Disorder of O-glucosylation |
121. Disorders of O-fucosylation |
122. Disorders of glycosylphosphatidylinositol biosynthesis |
123. Disorders of glycolipid glycosylation |
124. Disorders of dolichol metabolism |
125. Disorders of monosaccharide synthesis and interconversion |
126. Disorders of nucleotide-sugar synthesis |
127. Disorders of Golgi transport |
128. Glycosylation disorders of vesicular trafficking |
129. Disorders of Golgi homeostasis |
130. Disorder of deglycosylation |